Quality of Life in Type 2 Diabetes Mellitus Patients with Neuropsychological Deficits

  • Christos Marneras
  • Lambros MessinisEmail author
  • Aikaterini Ntoskou
  • Grigorios Nasios
  • Maria Martzoukou
  • Panagiotis Papathanasopoulos
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1196)


Objective: We investigated: (i) the cognitive performance of type 2 diabetes mellitus (T2DM) patients compared to healthy control participants and (ii) the Health-related Quality of life (HRQOL) of type 2 diabetics with neuropsychological deficits.

Method: We conducted a prospective study in (N = 44) T2DM patients and (N = 28) demographically matched healthy controls. All participants were assessed with a flexible comprehensive neuropsychological battery of tests that have been standardized in Greece and found to be sensitive in detecting cognitive deficits in type 2 diabetics. They were additionally assessed on measures of general intelligence, general mental state, and depression. They were also administered the WHO QOL-BREF self-report questionnaire to evaluate perceived health-related quality of life.

Results: Groups were well matched on baseline demographic characteristics and estimated premorbid intelligence. The groups did not differ on general mental state but varied in the encoding of verbal material, total verbal learning, delayed recall of verbal information, mental information processing speed, phonological and semantic verbal fluency and executive functions, set-shifting. Glycosylated hemoglobin levels and an interaction of age, education, and premorbid intelligence were the most important predictors of domain-specific neuropsychological performance. T2DM patients with deficits in verbal learning, executive functions, set-shifting, and semantic verbal fluency, had significantly lower QOL in the domains of psychological and environmental health, social relationships, and general health, respectively.

Conclusion: T2DM patients have cognitive deficits on several domains compared to healthy participants. Domain specific neuropsychological deficits in middle aged T2DM patients have a significant impact on HRQOL.


Type 2 Diabetes Mellitus (T2DM) Cognitive performance Neuropsychological Deficits Health Related quality of Life (HRQOL) 



Declared none.

Ethics Approval and Consent to Participate

The study was approved by the Ethics Committee of the University Hospital of Patras.

Human and Animal Rights

No animals were used in this study. For our human subjects, the study protocol and research was approved by the Ethics Committee of the University Hospital of Patras, according to the Helsinki Declaration of 1975, as revised in 2008.

Consent for Publication

Written consent was obtained from all participants of the present study after having been informed of the nature of the study they would take part in.

Conflict of Interest

The authors declare no conflict of interest, financial or otherwise.


  1. AI Hayek AA, Robert AA, AI Saeed A, Alzaid AA, AI Sabaan FS (2014) Factors associated with health-related quality of life among Saudi patients with type 2 diabetes mellitus: a cross-sectional survey. Diabetes Metab J 38(3):220–229CrossRefGoogle Scholar
  2. Aithal S, Vidyasagar CR, Venkatarathnamma PN, Patil NJ (2018) Quality of life in elderly Type 2 diabetes mellitus patients with mild cognitive impairment. Int J Recent Sci Res 9(3):24925–24928Google Scholar
  3. Apostolou T, Gokal R (2000) Quality of life after peritoneal dialysis. In: Gokal R, Khanna RT, Krediet R, Nolph KD (eds) Textbook of peritoneal dialysis. Kluwer Academic Publishers, Dordrecht, pp 709–735CrossRefGoogle Scholar
  4. Areosa Sastre A, Vernooij RW, Gonzalez-Colaco Harmand M, Martinez G (2017) Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database Syst Rev 15(6):CD003804. Scholar
  5. Argirokastritou E, Samanda T, Messinis L (2005) Preliminary normative data for the Symbol Digit Modalities Test (SDMT) in Greece. Poster Presentation at the 10th Panhellenic Congress of Psychology, IoanninaGoogle Scholar
  6. Armitage SG (1946) An analysis of certain psychological tests for the evaluation of brain injury. Psychological Monographs, 60, (Whole No 277)CrossRefGoogle Scholar
  7. Arvanitakis Z, Wilson RS, Bienias JL et al (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61(5):661–666PubMedCrossRefGoogle Scholar
  8. Awad N, Gagnon M, Messier C (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26(8):1044–1080PubMedCrossRefGoogle Scholar
  9. Beck AT, Steer RA, Brown GK (2000) BDI-Fast Screen for medical patients: manual. Psychological Corporation, San Antonio, TXGoogle Scholar
  10. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64–74PubMedCrossRefGoogle Scholar
  11. Biessels GJ, Deary I, Ryan CM (2008) Cognition and diabetes: a lifespan perspective. Lancet Neurol 7(2):184–190PubMedCrossRefGoogle Scholar
  12. Brands AMA, van den Berg E, Manshot SM et al (2007) A detailed profile of cognitive dysfunction and its relation to psychological distress in patients with type 2 diabetes mellitus. JINS 13(2):288–297PubMedGoogle Scholar
  13. Chamberlain SR, Odlaug BL, Schreiber CR, Grant JE (2012) Association between tobacco smoking and cognitive functioning in young adults. Am J Addict Suppl1:S14–S19CrossRefGoogle Scholar
  14. Chiang CK, Peng YS, Chiang SS, Yang CS, He YH, Hung KY et al (2004) Health-related quality of life of haemodialysis patients in Taiwan: a multicenter study. Blood Purif 22:490–498PubMedCrossRefGoogle Scholar
  15. Cuevas H, Stuifbergen A (2017) Perceived cognitive deficits are associated with diabetes self-management in a multiethnic sample. J Diabetes Metab Disord 16:7. Scholar
  16. Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes: systematic review of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRefGoogle Scholar
  17. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedPubMedCentralCrossRefGoogle Scholar
  18. Fountoulakis KN, Tsolaki M, Chantzi H, Kazis A (2000) Mini Mental State Examination (MMSE): a validation study in Greece. Am J Alzheimers Dis Other Dement 15:342–345CrossRefGoogle Scholar
  19. Ginieri-Coccossis M, Triantafillou E, Tomaras C et al (2012) Psychometric properties of WHOQOL-BREF in clinical and healthy Greek populations: incorporating new culture-relevant items. PSYCHIATRIKI 23(2):130–142PubMedGoogle Scholar
  20. Gow AJ, Johnson W, Pattie A et al (2011) Stability and change in intelligence from age 11 to ages 70, 79, and 87: the Lothian Birth Cohorts of 1921 and 1936. Psychol Aging 26:232–240PubMedCrossRefGoogle Scholar
  21. Koekhoek PS, Kapelle LJ, van den Berg E, Rutten Guy EHM, Jan Biessels G (2015) Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol 14:329–340CrossRefGoogle Scholar
  22. Kosmidis MH, Vlahou CH, Panagiotaki P, Kiosseoglou G (2004) The verbal fluency task in the Greek population: normative data and clustering and switching strategies. J Int Neuropsychol Soc 10:164–172PubMedCrossRefGoogle Scholar
  23. Lee JH, Choi Y, Jun C et al (2014) Neurocognitive changes and their Neural Correlates in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab 29:112–121CrossRefGoogle Scholar
  24. Lee Y, Smofsky A, Nykoliation P et al (2017) Cognitive impairment mediates workplace impairment in persons with Type 2 diabetes mellitus: results from the motivaction study. Can J Diabetes S1499–2671(17):30284. Scholar
  25. Lu Y, Wang N, Chen Y et al (2017) Health – related quality of life in type-2 diabetes patients: a cross-sectional study in East China. BMC Endocr Disord 17(1):38PubMedPubMedCentralCrossRefGoogle Scholar
  26. Mansur RB, Lee Y, Zhou AJ et al (2018) Determinants of cognitive function in individuals with type 2 diabetes mellitus: a meta – analysis. Ann Clin Psychiatry 30(1):38–50PubMedGoogle Scholar
  27. McCrimmon RJ, Ryan CM, Frier BM (2012) Diabetes and cognitive dysfunction. Lancet 16:2291–2299CrossRefGoogle Scholar
  28. Messinis L, Papathanasopoulos P (2009) Wechsler Abbreviated Scale of Intelligence (WASI) [Greek adaptation and preliminary normative data]. Unpublished data, neuropsychological laboratory, department of neurology, University of Patras Medical School, GreeceGoogle Scholar
  29. Messinis L, Tsakona I, Malefaki S, Papathanasopoulos P (2007) Normative data and discriminant validity of Rey’s verbal learning test for the Greek adult population. Arch Clin Neuropsychol 22:739–752PubMedCrossRefGoogle Scholar
  30. Ojo O, Brooke JE (2015) Evaluating the association between diabetes, cognitive decline and dementia. Int J Environ Res Public Health 12:8281–8294PubMedPubMedCentralCrossRefGoogle Scholar
  31. Palta P, Schneider ALC, Jan Biessels G et al (2014) Magnitude of cognitive dysfunction in adults with Type 2 diabetes: a Meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains. J Int Neuropsychol Soc 20(3):278–291PubMedPubMedCentralCrossRefGoogle Scholar
  32. Podoski N, Brixius K, Predel HG, Brinkmann C (2017) Effects of regular physical activity on the cognitive performance of type 2 diabetic patients: a systematic review. Metab Syndr Relat Disord 15(10):481–493CrossRefGoogle Scholar
  33. Prasad S, Cucillo L (2015) Impact of Tobacco smoking and type-2 Diabetes Mellitus on Public Health: a erebrovascular perspective. J Pharmacovigil Suppl 2.
  34. Prassana Kumar HR, Mahesh MG, Menon VB et al (2018) Patient self -reported quality of life assessment in Type 2 diabetes mellitus: a pilot study. Niger J Clin Pract 21:343–349Google Scholar
  35. Reijmer YD, van den Berg E, Ruis C, Kapelle LJ, Biessels GJ (2010) Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 26:5607–5519CrossRefGoogle Scholar
  36. Sadanand S, Balachandar R, Bharath S (2016) Memory and executive functions in persons with type 2 diabetes: a meta – analysis. Diabetes Metab Res Rev 32(2):132–142. Scholar
  37. Smith A (2002) Symbol Digit Modalities Test (SDMT). Manual (Revised). Western Psychological Services, Los Angeles, CAGoogle Scholar
  38. Sullivan MD, Katon WJ, Lovato LC (2013) Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial. JAMA Psychiat 70(10):1041–1047CrossRefGoogle Scholar
  39. Theofilou P (2009) Sociodemographic variables and their relationship with quality of life and the mental health of patients with end stage chronic renal failure. Pharmacoeconomia 39(3):5–11. (In Greek)Google Scholar
  40. Tomlin A, Sinclair A (2016) The influence of cognition on self-management of type 2 diabetes in older people. Psychol Res Behav Manag 21(9):7–20. Scholar
  41. Trikkalinou A, Papazafiropoulou AK, Melidonis A (2017) Type 2 diabetes and quality of life. World J Diabetes 8(4):120–129PubMedPubMedCentralCrossRefGoogle Scholar
  42. Twig G, Gluzman I, Tirosh A et al (2014) Cognitive function and the risk for diabetes among young men. Diabetes Care 37:2982–2988PubMedCrossRefGoogle Scholar
  43. Vaatainen S, Keinanen-Kiukaanniemi S, Saramies J et al (2014) Quality of life along the diabetes continuum: a cross – sectional view of health – related quality of life and general health status in middle – aged and older Finns. Qual Life Res 23(7):1935–1944PubMedCrossRefGoogle Scholar
  44. Vasilieva IA (2006) Quality of life in chronic hemodialysis patients in Russia. Hemodial Int 10:274–278PubMedCrossRefGoogle Scholar
  45. Vlahou CH, Kosmidis MH (2002) The Greek Trail Making Test: preliminary normative data for clinical and research use. Psychology 9:336–352Google Scholar
  46. Wechsler D (1999) Wechsler Abbreviated Scale of Intelligence (WASI): manual. The Psychological Corporation, New YorkGoogle Scholar
  47. Whitmer RA (2007) Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7(5):373–380PubMedCrossRefGoogle Scholar
  48. WHOQOL Group (2004) The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL Group. Qual Life Res 13:299–310CrossRefGoogle Scholar
  49. Wild S, Roglie G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053PubMedPubMedCentralCrossRefGoogle Scholar
  50. Wong RH, Scholey A, Howe PR (2014) Assessing premorbid cognitive ability in adults with type 2 diabetes mellitus – a review with implications for future intervention studies. Curr Diab Rep 14(11):547. Scholar
  51. Zurita-Cruz JN, Manuel-Apolinar L, Arellano-Flores ML et al (2018) Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study. Health Qual Life Outcomes 16(1):94PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Christos Marneras
    • 1
  • Lambros Messinis
    • 2
    Email author
  • Aikaterini Ntoskou
    • 2
  • Grigorios Nasios
    • 3
  • Maria Martzoukou
    • 3
  • Panagiotis Papathanasopoulos
    • 4
  1. 1.Department of NursingUniversity Hospital of PatrasPatrasGreece
  2. 2.Neuropsychology Section, University Hospital of Patras, Departments of Psychiatry and Neurology, University of Patras Medical SchoolPatrasGreece
  3. 3.University of Ioannina, Department of Speech and Language TherapyIoanninaGreece
  4. 4.University of Patras Medical SchoolPatrasGreece

Personalised recommendations